CurifyLabs

CurifyLabs develops the CurifyLabs Compounding System Solution, an automated platform for non-sterile compounding of personalized medicines. The system combines GMP-manufactured excipient bases (CuraBlend), compounding robotics inspired by 3D printing, integrated in-process quality control, software, and a formulation library with digital batch records.

Its customers are pharmacies and hospital pharmacies. The website says the system is in clinical use with customers in Europe and the US and lists customer sites in the US, Germany, Finland, Estonia and Sweden. The website does not describe pricing or the revenue model.

The company was founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius. Its registered headquarters is CurifyLabs Oy in Helsinki, with subsidiaries listed in Jacksonville, Florida and Bad Laer, Germany. Its website lists six open roles: US sales, marketing and customer success, plus a robotics production engineer and a finance operations specialist in Helsinki.

Product: Compounding System Solution: automated non-sterile compounding platform with excipient bases, compounding hardware, in-process QC software and a formulation library.